Antineoplaston Therapy in Treating Patients With Primary Liver Cancer

Summary

Current therapies for Primary Liver Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Primary Liver Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with advanced Head and Neck Cancer.

Timeline

Start

1977-03-21

Primary completion

1999-10-17

Completion

1999-10-17

Drugs

Indications